Arbevel, Bpifrance, Novo Holdings, Seventure, Sofinnova Partners, M&L Healthcare, European Innovation Council and Ysios Capital led a $40m Series C round in CorWave, a developer of an implantable heart pump. These new funds will enable CorWave to finalize development of its initial product, expand a manufacturing infrastructure, complete regulatory testing required to conduct human implants, and start its human clinical trials.